ELIZABETH WATSON: Open Payments
NPI 1194150011 · MYRTLE BEACH, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$549 in 19 payments from 9 companies in 2025. Trend: 2023 $812 · 2024 $526 · 2025 $549
Food & beverage: $549
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $125 |
| Organogenesis Inc. | 4 | $107 |
| ABBVIE INC. | 5 | $106 |
| UCB, Inc. | 3 | $83 |
| Lilly USA, LLC | 2 | $33 |
| GENZYME CORPORATION | 1 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| AtriCure, Inc. | 1 | $19 |
Products named: LEVULAN KERASTICK, SKYRIZI, Bimzelx, NOVACHOR, TALTZ, AFFINITY, COSENTYX, LIBTAYO.
Industry payments across SC — which companies pay providers there.
